HEALTH-RELATED QUALITY OF LIFE RESULTS FROM THE RANDOMIZED PHASE II TAVAREC TRIAL ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB IN 1p/19q INTACT FIRS RECURRENCE WHO GRADE II AND III GLIOMA (EORTC 26091)

Autor: Reijneveld, J.C., Coens, C., Taphoorn, M.J.B., Smitt, P.S., Clement, P.M., Idbaih, A., Vos, F. de, Klein, M., Wick, W.G., Mulholland, P., Lewis, J., Golfinopoulos, V., Bottomley, A., Bent, M. van den
Jazyk: angličtina
Rok vydání: 2017
Zdroj: Neuro-Oncology, 19, 203-203
Databáze: OpenAIRE